Impact of the n-6: N-3 long-chain PUFA ratio during pregnancy and lactation on offspring neurodevelopment: 5-year follow-up of a randomized controlled trial

European Journal of Clinical Nutrition

Volumn 71, Issue 9, 2017, Pages 1114-1120

  Brei, C ^a   Stecher, L ^a   Brunner, S ^a   Ensenauer, R ^b,c   Heinen, F ^c   Wagner, P D ^d   Hermsdorfer J ^d   Hauner, H ^a,d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; EDIBLE OIL;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAND MOVEMENT; HUMAN; INFANT; LACTATION; MAJOR CLINICAL STUDY; MALE; MATERNAL NUTRITION; NERVE CELL DIFFERENTIATION; PREGNANCY; PROGENY; RANDOMIZED CONTROLLED TRIAL; UMBILICAL CORD BLOOD; CHILD DEVELOPMENT; FETUS BLOOD; METABOLISM; PRESCHOOL CHILD; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DIETARY FATS, UNSATURATED; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FETAL BLOOD; HUMANS; LACTATION; MALE; PREGNANCY; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 85028917256     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2017.79     Document Type: Article

References (47)

1. Kapur A. Pregnancy: A window of opportunity for improving current and future health. Int J Gynaecol Obstet 2011; 115(Suppl 1): S50-S51.
2. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 2001; 40: 1-94.
3. Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr 2007; 137: 855-859.
4. Rogers LK, Valentine CJ, Keim SA. DHA supplementation: current implications in pregnancy and childhood. Pharmacol Res 2013; 70: 13-19.
5. Lauritzen L, Carlson SE. Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status. Matern Child Nutr 2011; 7(Suppl 2): 41-58.
6. Koletzko B, Lien E, Agostoni C, Bohles H, Campoy C, Cetin I et al. The roles of longchain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 2008; 36: 5-14.
7. Hibbeln JR, Davis JM, Steer C, Emmett P, Rogers I, Williams C et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): An observational cohort study. Lancet 2007; 369: 578-585.
8. Oken E, Radesky JS, Wright RO, Bellinger DC, Amarasiriwardena CJ, Kleinman KP et al. Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am J Epidemiol 2008; 167: 1171-1181.
9. Mendez MA, Torrent M, Julvez J, Ribas-Fito N, Kogevinas M, Sunyer J. Maternal fish and other seafood intakes during pregnancy and child neurodevelopment at age 4 years. Public Health Nutr 2009; 12: 1702-1710.
10. Steer CD, Lattka E, Koletzko B, Golding J, Hibbeln JR. Maternal fatty acids in pregnancy, FADS polymorphisms, and child intelligence quotient at 8 y of age. Am J Clin Nutr 2013; 98: 1575-1582.
11. Cheruku SR, Montgomery-Downs HE, Farkas SL, Thoman EB, Lammi-Keefe CJ. Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning. Am J Clin Nutr 2002; 76: 608-613.
12. Krabbendam L, Bakker E, Hornstra G, van Os J. Relationship between DHA status at birth and child problem behaviour at 7 years of age. Prostaglandins Leukot Essent Fatty Acids 2007; 76: 29-34.
13. Bakker EC, Hornstra G, Blanco CE, Vles JS. Relationship between long-chain polyunsaturated fatty acids at birth and motor function at 7 years of age. Eur J Clin Nutr 2009; 63: 499-504.
14. Jacobson JL, Jacobson SW, Muckle G, Kaplan-Estrin M, Ayotte P, Dewailly E. Beneficial effects of a polyunsaturated fatty acid on infant development: evidence from the inuit of arctic Quebec. J Pediatr 2008; 152: 356-364.
15. Meldrum S, Dunstan JA, Foster JK, Simmer K, Prescott SL. Maternal fish oil supplementation in pregnancy: A 12 year follow-up of a randomised controlled trial. Nutrients 2015; 7: 2061-2067.
16. Campoy C, Escolano-Margarit MV, Anjos T, Szajewska H, Uauy R. Omega 3 fatty acids on child growth, visual acuity and neurodevelopment. Br J Nutr 2012; 107(Suppl 2): S85-106.
17. Dziechciarz P, Horvath A, Szajewska H. Effects of n-3 long-chain polyunsaturated fatty acid supplementation during pregnancy and/or lactation on neurodevelopment and visual function in children: A systematic review of randomized controlled trials. J Am Coll Nutr 2010; 29: 443-454.
18. Hadders-Algra M. Prenatal and early postnatal supplementation with long-chain polyunsaturated fatty acids: neurodevelopmental considerations. Am J Clin Nutr 2011; 94(6 Suppl): 1874s-1879s.
19. Gould JF, Smithers LG, Makrides M. The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: A systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2013; 97: 531-544.
20. Hauner H, Vollhardt C, Schneider KT, Zimmermann A, Schuster T, Amann-Gassner U. The impact of nutritional fatty acids during pregnancy and lactation on early human adipose tissue development. Rationale and design of the INFAT study. Ann Nutr Metab 2009; 54: 97-103.
21. Hauner H, Much D, Vollhardt C, Brunner S, Schmid D, Sedlmeier EM et al. Effect of reducing the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on infant adipose tissue growth within the first year of life: An open-label randomized controlled trial. Am J Clin Nutr 2012; 95: 383-394.
22. Much D, Brunner S, Vollhardt C, Schmid D, Sedlmeier EM, Bruderl M et al. Effect of dietary intervention to reduce the n-6/n-3 fatty acid ratio on maternal and fetal fatty acid profile and its relation to offspring growth and body composition at 1 year of age. Eur J Clin Nutr 2013; 67: 282-288.
23. Much D, Brunner S, Vollhardt C, Schmid D, Sedlmeier EM, Bruderl M et al. Breast milk fatty acid profile in relation to infant growth and body composition: results from the INFAT study. Pediatr Res 2013; 74: 230-237.
24. Brei C, Stecher L, Much D, Karla MT, Amann-Gassner U, Shen J et al. Reduction of the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on offspring body composition: follow-up results from a randomized controlled trial up to 5 y of age. Am J Clin Nutr 2016; 103: 1472-1481.
25. Ireton H. Child Development Inventory Manual. Behavior Science Systems, Inc: Minneapolis, MN, USA, 1992, 1-39.
26. Brandstetter G, Siebler V, Schneider H, Grässle A, Steinmacher J, Bode H. Elternfragebogen zur Entwicklung im Kleinkindalter (EFkE)-ein Screeninginstrument: I. Normierung. Kinderarztl Prax 2002; 5: 338-344.
27. Brandstetter G, Bode H, Ireton HR. Elternfragebogen zur kindlichen Entwicklung (EFkE), Manual, 1st edn. Verlag Alexander Möckl: Augsburg, Germany, 2003.
28. Hermsdörfer J, Mai N, Marquardt C. Evaluation of precision grip using pneumatically controlled loads. J Neurosci Methods 1992; 45: 117-126.
29. Uttner I, Mai N, Esslinger O, Danek A. Quantitative evaluation of mirror movements in adults with focal brain lesions. Eur J Neurol 2005; 12: 964-975.
30. Uttner I, Kraft E, Nowak DA, Muller F, Philipp J, Zierdt A et al. Mirror movements and the role of handedness: isometric grip forces changes. Motor Control 2007; 11: 16-28.
31. Doig KB, Macias MM, Saylor CF, Craver JR, Ingram PE. The child development inventory: A developmental outcome measure for follow-up of the highrisk infant. J Pediatr 1999; 135: 358-362.
32. Brandstetter G. Manualeinlage-Ergänzung zum Kapitel 3. 3. Reliabilität und Validität, 2005. In: Brandstetter G, Bode H, Ireton HR. Elternfragebogen zur kindlichen Entwicklung (EFkE), Manual, 1st edn. Verlag Alexander Möckl: Augsburg, Germany, 2003.
33. Meldrum SJ, Smith MA, Prescott SL, Hird K, Simmer K. Achieving definitive results in long-chain polyunsaturated fatty acid supplementation trials of term infants: factors for consideration. Nutr Rev 2011; 69: 205-214.
34. D'Agati E, Casarelli L, Pitzianti MB, Pasini A. Overflow movements and white matter abnormalities in ADHD. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 441-445.
35. Barnea-Goraly N, Menon V, Eckert M, Tamm L, Bammer R, Karchemskiy A et al. White matter development during childhood and adolescence: A cross-sectional diffusion tensor imaging study. Cereb Cortex 2005; 15: 1848-1854.
36. Kuratko CN, Barrett EC, Nelson EB, Salem N Jr. The relationship of docosahexaenoic acid (DHA) with learning and behavior in healthy children: A review. Nutrients 2013; 5: 2777-2810.
37. Koerte I, Eftimov L, Laubender RP, Esslinger O, Schroeder AS, Ertl-Wagner B et al. Mirror movements in healthy humans across the lifespan: effects of development and ageing. Dev Med Child Neurol 2010; 52: 1106-1112.
38. Janssen CI, Kiliaan AJ. Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration. Prog Lipid Res 2014; 53: 1-17.
39. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003; 111: e39-e44.
40. Helland IB, Smith L, Blomen B, Saarem K, Saugstad OD, Drevon CA. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 2008; 122: e472-e479.
41. Escolano-Margarit MV, Ramos R, Beyer J, Csabi G, Parrilla-Roure M, Cruz F et al. Prenatal DHA status and neurological outcome in children at age 5. 5 years are positively associated. J Nutr 2011; 141: 1216-1223.
42. Campoy C, Escolano-Margarit MV, Ramos R, Parrilla-Roure M, Csabi G, Beyer J et al. Effects of prenatal fish-oil and 5-methyltetrahydrofolate supplementation on cognitive development of children at 6. 5 y of age. Am J Clin Nutr 2011 94 (6 Suppl): 1880S-1888S.
43. Makrides M, Gould JF, Gawlik NR, Yelland LN, Smithers LG, Anderson PJ et al. Fouryear follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA 2014; 311: 1802-1804.
44. Gould JF, Treyvaud K, Yelland LN, Anderson PJ, Smithers LG, McPhee AJ et al. Prenatal supplementation with DHA improves attention at 5 y of age: A randomized controlled trial. JAMA 2017; 317: 1173-1175.
45. Ramakrishnan U, Gonzalez-Casanova I, Schnaas L, DiGirolamo A, Quezada AD, Pallo BC et al. Prenatal supplementation with DHA improves attention at 5 y of age: A randomized controlled trial. Am J Clin Nutr 2016; 104: 1075-1082.
46. Dunstan JA, Simmer K, Dixon G, Prescott SL. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: A randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2008; 93: F45-F50.
47. Ghys A, Bakker E, Hornstra G, van den Hout M. Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum Dev 2002; 69: 83-90.